Literature DB >> 10983480

Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review.

F A Luscombe1.   

Abstract

Irritable Bowel Syndrome (IBS) is a chronic recurring disorder with variable illness episodes that may continue for many years. Diagnosis is based on symptoms such as abdominal pain and irregular bowel habits. These symptoms, plus the influence of psychological factors and extraintestinal symptoms, adversely affect the health-related quality of life (HRQoL) of individuals with IBS. This paper summarizes publications relating to the characteristics of IBS and associated HRQoL. Significantly lower scores on both the physical and mental health scales of the Short Form-36 are reported for individuals with IBS symptoms as compared with asymptomatic controls and US norms. IBS negatively affects general health, vitality, social functioning, bodily pain, diet, sexual function, sleep, and is associated with lost time from work. IBS-specific instruments that incorporate many of these domains have recently become available. HRQoL appears to correlate with IBS symptom severity and influences decisions to seek medical care. Psychosocial problems are also linked with IBS in relation to health care utilization. However, the full burden of this painful illness is still unknown since only 25-60% of individuals suffering from IBS symptoms see a physician for their illness.

Entities:  

Mesh:

Year:  2000        PMID: 10983480     DOI: 10.1023/a:1008970312068

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  91 in total

Review 1.  Anxiety and the irritable bowel syndrome: psychiatric, medical, or both?

Authors:  R B Lydiard
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

2.  Adequate relief as an endpoint in clinical trials in irritable bowel syndrome.

Authors:  A W Mangel; B A Hahn; A T Heath; A R Northcutt; S Kong; G E Dukes; D McSorley
Journal:  J Int Med Res       Date:  1998 Mar-Apr       Impact factor: 1.671

3.  Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.

Authors:  D L Patrick; D A Drossman; I O Frederick; J DiCesare; K L Puder
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

4.  Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms.

Authors:  B A Hahn; W B Saunders; W C Maier
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

5.  Presidential address: Gastrointestinal illness and the biopsychosocial model.

Authors:  D A Drossman
Journal:  Psychosom Med       Date:  1998 May-Jun       Impact factor: 4.312

6.  Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome.

Authors:  R C Smith; D S Greenbaum; J B Vancouver; R C Henry; M A Reinhart; R B Greenbaum; H A Dean; J E Mayle
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

7.  Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.

Authors:  N J Talley; P Boyce; M Jones
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

8.  Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan.

Authors:  R J Schlemper; S D van der Werf; J P Vandenbroucke; I Biemond; C B Lamers
Journal:  Scand J Gastroenterol Suppl       Date:  1993

9.  Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease.

Authors:  E A Walker; A N Gelfand; M D Gelfand; W J Katon
Journal:  Psychol Med       Date:  1995-11       Impact factor: 7.723

10.  Depression and functional bowel disorders in gastrointestinal outpatients.

Authors:  J D Rose; A H Troughton; J S Harvey; P M Smith
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

View more
  11 in total

1.  Melatonin: a novel treatment for IBS?

Authors:  S Elsenbruch
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  An antiemetic for irritable bowel syndrome?

Authors:  Robert Levy; Jason Corbo; Shailendra Prasad
Journal:  J Fam Pract       Date:  2014-10       Impact factor: 0.493

3.  Improved health-related quality of life after surgical management of severe refractory constipation-dominant irritable bowel syndrome.

Authors:  Jennifer Y Lam; Biniam Kidane; Farouq Manji; Brian M Taylor
Journal:  Int Surg       Date:  2015-01

4.  Association between intimate partner violence and irritable bowel syndrome: a population-based study in Nicaragua.

Authors:  Sylvia Becker-Dreps; Douglas Morgan; Rodolfo Peña; Loreto Cortes; Christopher F Martin; Eliette Valladares
Journal:  Violence Against Women       Date:  2010-07

Review 5.  Costs of irritable bowel syndrome in the UK and US.

Authors:  Stefanie Maxion-Bergemann; Frank Thielecke; Florian Abel; Rito Bergemann
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 6.  Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome.

Authors:  Ron Schey; Satish S C Rao
Journal:  Dig Dis Sci       Date:  2011-04-27       Impact factor: 3.199

7.  Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.

Authors:  Xavier Badia; Fermin Mearin; Agustin Balboa; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Mentse Roset; Nicholas J Talley
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  A comparison of irritable bowel syndrome patients managed in primary and secondary care: the Episode IBS study.

Authors:  Graeme D Smith; Douglas T Steinke; Moira Kinnear; Kay I Penny; Nim Pathmanathan; Ian D Penman
Journal:  Br J Gen Pract       Date:  2004-07       Impact factor: 5.386

9.  Psychological distress and impaired quality of life common among community-dwelling adults with lower gastrointestinal disorders.

Authors:  Tara W Strine; Daniel P Chapman; Nicole Flowers
Journal:  Dig Dis Sci       Date:  2006-12-14       Impact factor: 3.487

Review 10.  Pathophysiology and management of irritable bowel syndrome.

Authors:  J E Kellow
Journal:  Korean J Intern Med       Date:  2001-09       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.